Troyen A. Brennan - 26 Oct 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Troyen Brennan
Issuer symbol
CVS
Transactions as of
26 Oct 2021
Net transactions value
-$2,903,956
Form type
4
Filing time
28 Oct 2021, 16:34:55 UTC
Previous filing
07 Sep 2021
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $4,378,660 +80,802 +58% $54.19 221,003 26 Oct 2021 Direct
transaction CVS Common Stock Sale $172,040 -1,955 -0.88% $88.00 219,048 26 Oct 2021 Direct
transaction CVS Common Stock Sale $7,110,576 -80,802 -37% $88.00 138,246 26 Oct 2021 Direct F1
holding CVS Common Stock (restricted) 4,805 26 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -80,802 -50% $0.000000 80,803 26 Oct 2021 Common Stock 80,802 $54.19 Direct F2
holding CVS Stock Option 47,937 26 Oct 2021 Common Stock 47,937 $102.26 Direct F3
holding CVS Stock Option 53,772 26 Oct 2021 Common Stock 53,772 $104.82 Direct F4
holding CVS Stock Option 75,134 26 Oct 2021 Common Stock 75,134 $78.05 Direct F5
holding CVS Stock Option 21,894 26 Oct 2021 Common Stock 21,894 $62.21 Direct F6
holding CVS Stock Option 112,637 26 Oct 2021 Common Stock 112,637 $58.34 Direct F7, F8
holding CVS Stock Option 99,344 26 Oct 2021 Common Stock 99,344 $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.